AAAAAA

   
Results: 1-9 |
Results: 9
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
Authors: Pal, R Venzon, D Letvin, NL Santra, S Montefiori, DC Miller, NR Tryniszewska, E Lewis, MG VanCott, TC Hirsch, V Woodward, R Gibson, A Grace, M Dobratz, E Markham, PD Hel, Z Nacsa, J Klein, M Tartaglia, J Franchini, G
Citation: R. Pal et al., ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency, J VIROLOGY, 76(1), 2002, pp. 292-302
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
Authors: Belyakov, IM Hel, Z Kelsall, B Kuznetsov, VA Ahlers, JD Nacsa, J Watkins, DI Allen, TM Sette, A Altman, J Woodward, R Markham, PD Clements, JD Franchini, G Strober, W Berzofsky, JA
Citation: Im. Belyakov et al., Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques, NAT MED, 7(12), 2001, pp. 1320-1326
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge
Authors: Patterson, LJ Robey, F Muck, A Van Remoortere, K Aldrich, K Richardson, E Alvord, WG Markham, PD Cranage, M Robert-Guroff, M
Citation: Lj. Patterson et al., A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge, AIDS RES H, 17(9), 2001, pp. 837-849
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques
Authors: Patterson, LJ Peng, B Abimiku, AG Aldrich, K Murty, L Markham, PD Kalyanaraman, VS Alvord, WG Tartaglia, J Franchini, G Robert-Guroff, M
Citation: Lj. Patterson et al., Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques, AIDS, 14(16), 2000, pp. 2445-2455
Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology
Authors: Romano, JW Shurtliff, RN Dobratz, E Gibson, A Hickman, K Markham, PD Pal, R
Citation: Jw. Romano et al., Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology, J VIROL MET, 86(1), 2000, pp. 61-70
Patterns of genomic sequence diversity among their simian immunodeficiencyviruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a naturallentivirus reservoir
Authors: Beer, BE Bailes, E Dapolito, G Campbell, BJ Goeken, RM Axthelm, MK Markham, PD Bernard, J Zagury, D Franchini, G Sharp, PM Hirsch, VM
Citation: Be. Beer et al., Patterns of genomic sequence diversity among their simian immunodeficiencyviruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a naturallentivirus reservoir, J VIROLOGY, 74(8), 2000, pp. 3892-3898
CD8(+) lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy
Authors: Leno, M Carter, L Venzon, DJ Romano, J Markham, PD Limbach, K Tartaglia, J Paoletti, E Benson, J Franchini, G Robert-Guroff, M
Citation: M. Leno et al., CD8(+) lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy, AIDS RES H, 15(5), 1999, pp. 461-470
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251
Authors: Buge, SL Murty, L Arora, K Kalyanaraman, VS Markham, PD Richardson, ES Aldrich, K Patterson, LJ Miller, CJ Cheng, SM Robert-Guroff, M
Citation: Sl. Buge et al., Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251, J VIROLOGY, 73(9), 1999, pp. 7430-7440
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251 (vol 73, pg 7430, 1999)
Authors: Buge, SL Murty, L Arora, K Kalyanaraman, VS Markham, PD Richardson, ES Aldrich, K Patterson, LJ Miller, CJ Cheng, SM Robert-Guroff, M
Citation: Sl. Buge et al., Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251 (vol 73, pg 7430, 1999), J VIROLOGY, 73(11), 1999, pp. 9692-9692
Risultati: 1-9 |